• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: COOK IRELAND LTD ZILVER PTX 35 DRUG-ELUTING STENT; NIU STENT, SUPERFICIAL FEMORAL ARTERY, DRUG-ELUTING

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

COOK IRELAND LTD ZILVER PTX 35 DRUG-ELUTING STENT; NIU STENT, SUPERFICIAL FEMORAL ARTERY, DRUG-ELUTING Back to Search Results
Model Number G38486
Medical Device Problem Code Expiration Date Error (2528)
Health Effect - Clinical Code No Known Impact Or Consequence To Patient (2692)
Date of Event 01/27/2020
Type of Reportable Event Malfunction
Additional Manufacturer Narrative
Investigation is still pending, a follow up mdr will be submitted to include the investigation conclusions.
 
Event or Problem Description
Expired zilver ptx placed in patient.No issues during the procedure.No adverse effects reported.No additional interventions needed.The physician put the patients on antibiotics after the case because he was worried about the sterility of the stent.Patient had no issues at time of/immediately after procedure.Facility will not be reporting to the fda.
 
Event or Problem Description
Expired zilver ptx placed in patient.No issues during the procedure.No adverse effects reported.No additional interventions needed.The physician put the patients on antibiotics after the case because he was worried about the sterility of the stent.Patient had no issues at time of/immediately after procedure.Facility will not be reporting to the fda.
 
Additional Manufacturer Narrative
This file was initially reported based on the potential risk of off label use, however off label use is defined as not using the device for its intended purpose or against the indication for use which in this case has not occurred.Following below investigation conclusions it has been determined that placement of an expired device is user error which is low risk and has driven re-assessment to non reportable.This report is therefore being submitted as a cancellation report.Device evaluation: the zisv6-35-125-7-40-ptx device of lot number c1489304 involved in this complaint was implanted in the patient and was not available for evaluation.With the information provided, a document based investigation was conducted.Document review: prior to distribution zisv6-35-125-7-40-ptx devices are subjected to a visual inspection and functional checks to ensure device integrity.These inspections and functional checks are outlined in internal procedures in place at cirl.A review of the manufacturing records for zisv6-35-125-7-40-ptx of lot number c1489304 did not reveal any discrepancies that could have contributed to this complaint issue.The review of relevant manufacturing records, confirms the failure mode has not previously occurred with the current lot number.Based on the information available to date, there is no evidence to suggest that there are any manufacturing issues associated with lot number c1489304.It should be noted that the instructions for use (ifu0118-5) states the following: ¿do not use stent after the ¿use by¿ date specified on the package.¿ there is evidence to suggest that the user did not follow the ifu.Root cause review: a definitive root cause of the user misreading the use by date or not checking the use by date of the device prior to implantation was identified from the available information.From the available information it is known that the device expired on 19 january 2020 and the date of the event was 27 january 2020.Summary: the complaint is confirmed based on customer testimony.According to the initial reporter, the physician prescribed a course of antibiotics to the patient as a precaution.However, it is also known from the information provided that the patient did not experience any adverse effects due to this occurrence.Complaints of this nature will continue to be monitored for potential emerging trends.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ZILVER PTX 35 DRUG-ELUTING STENT
Common Device Name
NIU STENT, SUPERFICIAL FEMORAL ARTERY, DRUG-ELUTING
Manufacturer (Section D)
COOK IRELAND LTD
o halloran road
limerick
MDR Report Key9755900
Report Number3001845648-2020-00128
Device Sequence Number16716541
Product Code NIU
UDI-Device Identifier10827002384863
UDI-Public(01)10827002384863(17)200119(10)C1489304
Combination Product (Y/N)N
Initial Reporter StateNJ
Initial Reporter CountryUS
PMA/510(K) Number
P100022
Number of Events Summarized1
Summary Report (Y/N)N
Reporter Type Manufacturer
Report Source company representative,health
Initial Reporter Occupation Other
Type of Report Initial,Followup
Report Date (Section B) 04/16/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Operator of Device Health Professional
Device Expiration Date01/19/2020
Device Model NumberG38486
Device Catalogue NumberZISV6-35-125-7-40-PTX
Device Lot NumberC1489304
Was Device Available for Evaluation? No
Was the Report Sent to FDA? No
Distributor Facility Aware Date01/27/2020
Event Location Hospital
Initial Date Received by Manufacturer 02/11/2020
Supplement Date Received by Manufacturer02/11/2020
Initial Report FDA Received Date02/26/2020
Supplement Report FDA Received Date05/13/2020
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Patient Sequence Number1
-
-